Clinical Trials Browser

Phase 1 × Neuroectodermal Tumors, Primitive × NET × Clear all

NCT02355535 2020-09-24

Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1

Phase 1 Completed

Adenoma, Islet Cell, Neuroectodermal Tumors, Primitive, Neuroendocrine Tumors